David Wohl, MD David Alain Wohl, MD That there are only a handful of Ebola-ologists in the world is something that Dr. Wohl, the Site Leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, realized when the massive Ebola outbreak started to peak in 2014. Ebola raged across West Africa and cases … Read more

Speaker: Christopher Klipstein, MD Topic: “On Lecturing: Tips on Delivering an Effective Lecture” Dr. Klipstein, a Professor of Medicine, was raised in Rochester, NY. He graduated from Williams College in 1989. After spending one year in New York City teaching 7th and 9th grade math, he returned home to attend the University of Rochester School … Read more

Gregg J. Silverman, MD Speaker: Gregg Silverman, MD Topic: “Rheumatoid Arthritis: From Genes to Joints” Dr. Silverman is a Professor of Medicine and Pathology at NYU School of Medicine, and Co-Director of the Muskuloskeletal Center of Excellence.

The 2016 Whitehead Lecture took place on August 17 and was delivered by Dr. Frank Church, Professor of Medicine from the Department of Pathology and Laboratory Medicine. The annual event, which serves as an unofficial convocation for the UNC School of Medicine, has been held since 1947. Following the lecture, awards were presented to faculty and students in the School of Medicine. Department of Medicine faculty and residents were among those honored.

What are the challenges that patients face in communicating with their physicians, and how do questionnaires work to help? Dr. Ron Falk interviews Dr. Ethan Basch in this podcast about patient-reported outcomes research. Dr. Basch is a Professor of Medicine in the Division of Hematology and Oncology at UNC, and a Professor of Health Policy and Management in the School of Public Health. He is the Director of the UNC Cancer Outcomes Research Program, and serves as an Associate Editor for the Journal of the American Medical Association.

What is new in the field of breast cancer care and research, and what is UNC’s involvement? Dr. Ron Falk interviews Dr. Lisa Carey in this podcast about breast cancer research and care. Dr. Carey is the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, and Chief of the Division of Hematology and Oncology at UNC. Dr. Carey is the Medical Director of the UNC Breast Center, the Physician-in-Chief of the North Carolina Cancer Hospital, and Associate Director of Clinical Research at UNC Lineberger Comprehensive Cancer Center.

Ten specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual “America’s Best Hospitals” issue. Four of our ranked specialties were ranked highest in the state. Across the state, our system performed well. UNC Hospitals, UNC REX Hospital and High Point Regional Hospital ranked No. 2, No. 10 and No. 16, respectively.

  Satish Gopal, MD, MPH Satish Gopal, MD, MPH Dr. Gopal went to medical school at Duke University, and trained in medicine-pediatrics at the University of Michigan. He completed medical oncology and infectious diseases fellowships at the University of North Carolina and is board certified in both disciplines. He lived in Tanzania from 2007 until … Read more

What should patients know about treatment with rituximab for ANCA vasculitis? What do physicians consider when starting a patient on this medication? Dr. Patrick Nachman and Dr. Ron Falk explain these details in a new episode of Chair’s Corner. Dr. Patrick Nachman is the Covington Distinguished Professor of Medicine in the Division of Nephrology and Hypertension at UNC, and he also serves as the Deputy Director for the UNC Kidney Center.

A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.

Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission, a study led by the University of North Carolina at Chapel Hill found. Researchers found a 93 percent reduction of HIV transmission when the HIV-infected person started antiretroviral therapy or ART at a higher CD4 cell count. The groundbreaking final results of the HIV Prevention Trials Network (HPTN) 052 study were published in the New England Journal of Medicine.

The UNC Center for Bronchiectasis Care recently opened in Meadowmont in Chapel Hill, NC. In this new Chair’s Corner podcast, Dr. Ron Falk interviews Dr. Peadar Noone, who is a Professor of Medicine in the Division of Pulmonary & Critical Care Medicine, and Medical Director for this new center. Dr. Noone answers some questions patients commonly ask about bronchiectasis and mycobacterial lung infections.